CME Symposium Information
The Nexus of Narcolepsy and Cardiometabolic Risk: Important Considerations and Implications for Management
May 22, 2021 | 10:55 AM - 11:55 AM |CMHC Masterclass | Eastern Time
This activity is supported by an educational grant from Jazz Pharmaceuticals, Inc.
Neurologists, primary care physicians, sleep disorder specialists, physician assistants, nurse practitioners, nurses, registered dieticians, and other healthcare professionals caring for patients in general and those with sleep disorders.
Several cardiometabolic comorbidities, including overweight/obesity, dyslipidemia, cardiovascular diseases, hypertension, and type 2 diabetes or insulin resistance, are common in patients with narcolepsy. Often these disorders are overlooked, but they have important implications in the management of these patients. Some medications used to treat symptoms of narcolepsy may have potential negative effects on cardiovascular health, including in patients that are sensitive to sodium, such as those with hypertension, heart failure, or impaired renal function. However, long-term data on the cardiovascular safety of narcolepsy treatments are generally lacking.. Given these gaps, clinicians would benefit from additional education on how to screen, identify, and better tailor the management of narcolepsy in these patients.
After completing this activity, the participant should be better able to:
- Recognize that cardiometabolic risk factors are common in patients with narcolepsy
- Describe the pathophysiological connections between narcolepsy and increased cardiometabolic risk
- Review the rationale and evidence behind the increased cardiometabolic risk and risk for major adverse cardiovascular events with commonly-used narcolepsy agents
- Summarize recent updates with new and emerging narcolepsy treatments
- Develop individualized treatment plans for patients with narcolepsy that aim to address EDS, cataplexy, and improve quality of life, while also incorporating strategies to reduce overall cardiometabolic risk and daily sodium intake
Virend K. Somers, MD, PhD (Chair)
Alice Sheets Marriott Professor
Mayo Clinic and Mayo Foundation
Lee A. Surkin, MD, FACC, FCCP, FASNC, FAASM
Board Certified in Cardiology, Nuclear Cardiology and Sleep Medicine
President, Empire Sleep Medicine
Founder, American Academy of Cardiovascular Sleep Medicine
Phyllis C. Zee, MD, PhD
Professor of Neurology
Northwestern University Feinberg School of Medicine
Director, Sleep Disorders Center
Northwestern Memorial Hospital
JOINT ACCREDITATION STATEMENT
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and CMHC. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
PHYSICIAN CONTINUING MEDICAL EDUCATION
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CONTINUING PHARMACY EDUCATION
Postgraduate Institute for Medicine designates this continuing education activity for 1.0 contact hour(s) (0.10 CEUs) of the Accreditation Council for Pharmacy Education.
This is an application-based activity. Universal Activity Numbers (UAN) JA4008162-9999-21-2771-L01-P.
For Pharmacists: Upon completion of the online evaluation, your credit will be submitted to CPE Monitor within 4-6 weeks. Pharmacists have up to thirty (30) days from the live event to complete the evaluation and claim credit.
CONTINUING NURSING EDUCATION
The maximum number of hours awarded for this Continuing Nursing Education activity is 1.0 contact hours. Pharmacotherapy contact hours for Advanced Practice Registered Nurses will be designated on your certificate.
CONTINUING DIETICIAN EDUCATION
This program offers 1.0 CPEUs for dieticians.
DISCLOSURE OF CONFLICTS OF INTEREST
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
A full listing of faculty disclosures will be provided here.
Planners and Managers
The PIM planners and managers have nothing to disclose. The CMHC planners and managers have nothing to disclose.
DISCLOSURE OF UNLABELED USE
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
REQUEST FOR CREDIT
**IMPORTANT FIRST STEP**
In order to access the evaluations you must first REGISTER or login on this website. Please note this is a separate site from www.cardiometabolichealth.org. To begin registration steps:
- Click here to register or login now and follow the instructions
- Once registered and logged in, return and register for the evaluations. Thank you.
|Evaluation Type||Credits Available||Evaluation Links Now Available|
|General Sessions||Learners may earn up to a maximum of 5.5 AMA/ACPE/ANCC/CDR credits. General Sessions CME information can be found here.||**Click to Access Gen Session Evaluation**|
|CME Symposium||An additional 1.0 credit hour may be earned for attending the midday CME Symposium. Symposium CME information can be found here.||**Click to Access Narcolepsy Symposium Evaluation**|
PLEASE NOTE: Evaluations must be completed by Monday, June 7.
For questions regarding the evaluation, please contact firstname.lastname@example.org
FEE INFORMATION & REFUND/CANCELLATION POLICY
There is no registration fee for participating and receiving CME/CE credit for this educational activity.